Meetings and publications | |
>> VHPB meetings |
CDC - UNICEF - VHPB - WHO
Istanbul, Turkey, March 15-17, 2006
Prevention and control of perinatal hepatitis B virus (HBV) transmission in the WHO European Region
Overall goal fo the meeting
To contribute to further prevention and control of perinatal hepatitis B virus (HBV) transmission in the countries of the European Region of the World Health Organization (WHO), by highlighting the advantages of newborn hepatitis B vaccination based on scientific evidence, and by sharing examples, experience, and knowledge regarding prevention of mother-to-child transmission of HBV.
Wednesday, March 15, 2006
Session 1 Opening and objectives
Chair: Nedret Emiroglu and Ludmila Mosina
09.00-09.10
Session 2 Epidemiology of perinatal HBV transmission
Chair: Nedret Emiroglu and Ludmila Mosina
09.10-09.40
Hepatitis B disease burden: a model for global estimates and impact of vaccination 132 Kb (.pdf) загрузите русскую версию
Susan Wang, Atlanta, Georgia, USA
09.40-10.00
Magnitude of perinatal HBV transmission in the Central Asian Republics 1,659 Kb (.pdf) загрузите русскую версию
Ludmila Mosina, Atlanta, Georgia, USA
10.00-10.20
Overview of HBV Infections and the vaccination policy in Turkey 532 Kb (.pdf) загрузите русскую версию
Meral Çiblak and Selim Badur, Istanbul, Turkey
10.35-11.00
Coffee break
Session 3 Scientific evidence on control and prevention of perinatal HBV transmission through immunisation
Chair: Andrei Lobanov and Wolfgang Jilg
11.00-11.30
Effectiveness of newborn hepatitis B vaccination programmes in achieving a reduction of chronic carriage – timing of the birth dose – administration of HBIg: a review 1,097 Kb (.pdf) загрузите русскую версию
Francis André, Belgium
11.30-11.50
Are immunogenicity and protective efficacy of hepatitis B vaccine related to different administration schedules? 625 Kb (.pdf) загрузите русскую версию
Voranush Chongsrisawat, Bangkok, Thailand
11.50-12.00
Long term efficacy of hepatitis B vaccination of newborns from HBs Ag positive mothers in Thailand 58 Kb (.pdf) загрузите русскую версию
Bernard Hoet, Belgium
12.05- 14.00
Lunch
Session 4 Prevention and control of perinatal HBV transmission: country status and experiences
Chair: Michael Favorov and Paolo Bonanni
14.00-14.20
Prevention of perinatal HBV transmission: evaluation of programmes and success stories from the Central Asian Republics – an example from Kazakhstan 1,826 Kb (.pdf) загрузите русскую версию
Michael Favorov, Atlanta, Georgia, USA
14.20-14.40
Experience from Armenia 968 Kb (.pdf) загрузите русскую версию
Armen Hayrapetyan, Armenia
14.40-15.00
Experience from Georgia 656 Kb (.pdf) загрузите русскую версию
Paata Imnadze, Georgia
15.30-15.50
Experience from Kyrgyzstan 265 Kb (.pdf) загрузите русскую версию
Joldosh Kalilov, Kyrgyzstan
15.50-16.10
Experience from Tajikistan 874 Kb (.pdf) загрузите русскую версию
Shamsiddin Jabirov, Tajikistan
16.10-16.30
Experience from Uzbekistan 1,943 Kb (.pdf) загрузите русскую версию
Erkin Musabaev, Uzbekistan
Thursday, March 16, 2006
SESSION 5 Prevention and control of perinatal HBV transmission: country status and experiences – continued
Chair: Daniel Lavanchy and John Ward
09.00-09.30
Hepatitis B vaccination of newborns in rural China: evaluation of an outside-the-cold-chain delivery strategy 590 Kb (.pdf) загрузите русскую версию
Lixia Wang, Beijing, PR China
09.30-10.00
Improving the hepatitis B birth dose in Indonesia, Vietnam, and Cambodia 1,015 Kb (.pdf) загрузите русскую версию
Carib Nelson, Seattle, United States
10.00-10.30
WHO recommendations and guidelines for the prevention of perinatal hepatitis B and use of hepatitis B vaccines 288 Kb (.pdf) загрузите русскую версию
Steven Wiersma, Geneva, Switzerland
Session 6 Mother-and-child Health
Chair: Daniel Lavanchy and John Ward
11.00-11.30
Hepatitis B vaccination and HBIg administration policies implemented for premature babies – vaccines concurrently administered with the hepatitis B vaccine birth dose 531Kb (.pdf) загрузите русскую версию
Vassiliki Papaevangelou, Athens, Greece
11.30-11.45
Introduction to the workshops
Pierre Van Damme, Antwerpen, Belgium
12.00-14.00
Lunch
Session 7 Workshops on how to prevent perinatal HBV transmission
Chair workgroup A: Andrei Lobanov and Michael Favorov
Chair workgroup B: Selim Badur and Daniel Shouval
14.00-17.00
Topics discussed in the workshops:
- Results from the country questionnaire: current situation, thresholds, evaluation methods, indicators used, …
- How do countries monitor the administration of the first dose and the timeliness of the first dose?
- Is there information available regarding the price per dose of hepatitis B vaccine your country is currently paying?
- What are the three most important contraindications for hepatitis B vaccination of newborns?
- Management of waste disposal.
- Storing hepatitis B vaccine at the recommended temperature.
- Country experiences: lessons learnt, opportunities, and outreach systems.
- How can hepatitis B vaccination fit into overall mother-and-child health programmes?
- Contraindications for newborn hepatitis B immunisation – examples from participating countries.
Friday, March 17, 2006
Session 8 Feedback form the workshops
Chair: Alessandro Zanetti and Harold Margolis
What is feasible? What are the thresholds? What is to be recommended and what is to be improved? How should be communicated in this context at country level? What is needed in terms of advocacy? Lessons learnt. How to implement the recommendations.
09.00-09.20
Feedback from Workshop 1
09.30-09.50
Feedback from Workshop 2
Session 9 Conclusions of the meeting and closing remarks
Chair: Mark Kane and Steven Wiersma
10.30-11.30
Conclusions and summary of the meeting 123 Kb (.pdf) загрузите русскую версию
David FitzSimons, Geneva, Switzerland
11.30 Close of the meeting